Back to all webinars
Navigating treatment options for stage I and II NSCLC
Steven Kao, Christopher Cao and Caian Zhou tackle unanswered questions surrounding the treatment of early-stage NSCLC, including whether neoadjuvant or adjuvant immunotherapy could be the future of treatment.
Speakers
Introduction
No entries
Which resection to perform for lung cancer – past, present, and future
No entries
Radiotherapy: State of the art in an era of evolving systemic therapies
No entries
Systemic therapies: How we got here
No entries
Systemic therapies: Immune checkpoint inhibitors
No entries
Panel discussion and Audience Q&A
No entries